S P East & South East England Specialist Pharmacy Services East of England, London, South Central & South East Coast S Medicines Use and Safety How to: Use the CQUIN framework for the development of an Outpatient Parenteral Antimicrobial Therapy (OPAT) service Introduction The Commissioning for Quality and Innovation (CQUIN) framework enables commissioners to reward excellence by linking a proportion of providers’ income to the achievement of local quality improvement goals.1 There are many options for the delivery of antimicrobial therapy other than the inpatient setting; outpatient or community clinics, community nursing in the patient’s residence, through home care with nurse administration or self-administration by the patient. A multidisciplinary OPAT service, either in the acute or community setting provides the structure for safer transfer and monitoring of these patients in the noninpatient setting. The benefits of an OPAT service are well documented; Improved patient choice and satisfaction2,3 Reduced risk of hospital acquired infection3 Improved antimicrobial stewardship4 QIPP efficiency gains from early discharge or avoided hospital admissions. OPAT episodes of care are estimated to cost around 50% of equivalent inpatient costs.5 Background A recent multi-centre audit of community IV therapy services across the East and South East of England demonstrated that there was often inefficient and unsafe transfer of patients, from acute to community services. Patients were sometimes discharged to community teams for the administration of IV antibiotics without any follow-up arranged.7 Best practice recommends that these patients and community teams should receive the support of a specialist OPAT multidisciplinary team to facilitate the safe transfer and regular review of these patients. 8 The British Society of Antimicrobial therapy have produced OPAT Good Practice Recommendations that describe the multidisciplinary team, governance tools and structures required to deliver a successful and high quality OPAT service.8 An interactive toolkit for development of a local business case to set up an OPAT service is also available together with an electronic patient management system to monitor the outcomes from an OPAT service.9,10 Rationale Development of an OPAT service is likely to result in significant cost savings and better patient experience but there are also substantial costs incurred in establishing a specialist service of high quality. The aim of this CQUIN framework is to provide the ‘pump-priming’ funding to establish the innovative service. The OPAT business case toolkit will prompt the provider to identify the costs involved to set up and run the service and to describe the benefits in terms of inpatient cost efficiencies and/or avoided hospital admissions. Identification and development of further care pathways that utilise the delivery of IV therapy in the non-inpatient setting will create a self-sustaining service for the future. Points to consider: Co-production between the provider and the commissioners is key to the successful design and implementation of a CQUIN Detailed information on PbR tariffs and local contracts will be required for the financial modelling It is useful to identify a senior managerial ‘champion’ within the provider who will support the clinicians with the development and implementation of the service If considering using a commercial organisation to provide homecare services then a robust service specification will be required S P S Medicines Use and Safety Sample CQUIN Framework Acute/Community providers Goal Name Indicator Number Indicator Name Indicator weighting Description of Indicator Numerator Denominator Rationale for Inclusion Data source Frequency of data collection Organisation responsible for data collection Frequency of reporting to commissioner Baseline period/date Baseline value Final indicator period/date (on which payment is based) Final indicator value (payment threshold) Rules for calculation of payment due at year end Outpatient Antimicrobial Therapy (OPAT) [] Development of an Outpatient Antimicrobial Therapy (OPAT) service [% of CQUIN fund available to this goal/indicator] This CQUIN aims to support providers to develop an OPAT service that is in line with best practice and will facilitate the safe early discharge or admission avoidance for patients who are appropriate to receive antimicrobial therapy in the non-inpatient setting The number of patients administered IV antibiotics in a non-inpatient setting who are receiving the standards of care outlined in the OPAT good practice recommendations (Q3 onwards) The number of inpatients assessed as appropriate to receive IV antibiotics in a non-inpatient setting (See introduction and rational above) Provider’s OPAT database 10 Business case in Q1, Progress report on project implementation in Q2, Monthly outcome data from the beginning of Q3 onwards Provider Quarterly for Q1 -Q2 Monthly for Q3 -Q4 (see below) Q1 £X to be negotiated by provider and commissioner (suggest between £25K £75K) Q4 £X to be negotiated by provider and commissioner (suggest between £175K £250K) The CQUIN payment could be triggered in stages – see below Milestones: Date/Period Rules for Achievement of milestones Reporting Deadline Q1 Provide commissioners with model and business plan for an OPAT service using the OPAT business case Toolkit 9 Put in place governance tools and service in line with OPAT Good practice recommendations8 Run pilot and provide monthly monitoring data using the OPAT Patient Management system10 Evaluate pilot (including patient satisfaction survey) and continue to provide monthly data to year end with a target of providing proof that it is a financially sustainable service. End of Q1 %weighting for payment at 100% 10% End of Q2 20% Q3 30% Q4 40% Q2 Q3 Q4 CQUIN Framework for OPAT service – October 2012 Vs1 (EC) 2 S P S Medicines Use and Safety Quarter 1: Business case Set up OPAT project stakeholder group to design the OPAT service and identify patient groups and care pathways that could utilise OPAT services. The provider will be required to present an internally approved business case to the commissioners outlining the service design and costs/benefits analysis, by the end of Q1. Quarter 2: Development of governance tools Develop the governance tools required for an OPAT service in line with best practice recommendations; policies, procedures, staff training, etc. Recruitment or redeployment of existing staff may be necessary. Quarter 3: Pilot phase Run a pilot service for a 3-6 month period seeing the minimum number of patients outlined in the business case. Use the OPAT Patient Management database to collate monthly outcomes and present these to the contractual Clinical Quality review meetings. Quarter 4: Evaluation and Outcomes reporting Evaluate and continue the OPAT service to year end. The evaluation will be expected to demonstrate how the service will be sustained for future years and may include the development of further care pathways that utilise the OPAT service. It should also include a patient satisfaction survey. References: 1. Department of Health (2008) Using the Commissioning for Quality and Innovation (CQUIN) Framework 2. Kayley, J. (2008) Effective practice in community IV therapy. British Journal of Community Nursing. 13; 7: 323-4, 326-8 3. O’Hanlon S et al (2008) Delivering intravenous therapy in the community setting, Nursing Standard 22; 31: 44- 4. 48 Department of Health. Advisory Committee on Antimicrobial Resistance and Healthcare Associated Infection (ARHAI) (2011) Antimicrobial stewardship: Start smart - then focus. Link to DH Start smart - then focus (Accessed August 2012) 5. Chapman ALN et al (2009) Clinical efficacy and cost effectiveness of outpatient parenteral antibiotic therapy (OPAT): a UK perspective. J Antimicrob Chemother64:1316. 6. Lomas C. (2009) Nurse-led community IV therapy services save the NHS over one million in three years. Nursing Times 3 February 2009 7. Callaghan E. The Medicine Use and Safety Division of the East and South East England Specialist Pharmacy Service (2012). Community Intravenous Therapy. An audit of prescribing and administration. Link to audit report on NeLM (Accessed August 2012) Available Resources: 8. British Society for Antimicrobial Chemotherapy (2012). Good Practice Recommendations for outpatient parenteral antimicrobial therapy (OPAT) in adults in the UK: a consensus statement Available at: http://jac.oxfordjournals.org/content/early/2012/01/31/jac.dks003.full.pdf+html (Accessed Aug 12) 9. British Society for Antimicrobial Chemotherapy. OPAT Business case Toolkit Link to Toolkit (Accessed Aug 2012) 10. British Society for Antimicrobial Chemotherapy. OPAT Patient Management System Link to Information on database (Accessed Aug 2012) ©East & South East England Specialist Pharmacy Services CQUIN Framework for OPAT service – October 2012 Vs1 (EC) 3
© Copyright 2024